chartexchange

ELTP
ELITE PHARMS INC
stockOTC

EODNov 18, 2026
0.3585USD-3.016%(-0.0112)673,044
Loading…
Loading…
394.89M
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Northvale, NJ, USA
Previous Close
$0.37
Beta
0.31
52-Week High
$0.60 2025-11-18
52-Week Low
$0.21 2026-11-11
SMA 50
$0.25
SMA 200
$0.34
Avg. Vol 10D
1.10M
Avg. Vol 30D
752,987
Avg. Vol 90D
782,671
Relative Vol
1.44
836.29M
45,934
ELTP Profile

elite pharmaceuticals, inc. develops oral sustained and controlled release products. elite's strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. elite has four anda products partnered with tagi pharma; one anda has launched, two andas are in the process of a manufacturing site transfer and an additional anda is currently under review by the fda. elite also manufactures lodrane d® and receives royalties for lodrane d®, an allergy product partnered with ecr pharmaceuticals ("ecr"), a wholly owned subsidiary of hi-tech pharmacal ("hi-tech"). elite's lead pipeline products, eli-216, a once-daily abuse resistant oxycodone, and eli-154, a once-daily oxycodone, are novel sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provisio

ELTP Performance
PeriodPriceDateChangeBeta
1W0.242026-11-11+54.02%3.860
1M0.252026-10-19+47.41%-0.374
3M0.302026-08-18+21.80%-0.235
6M0.352026-05-18+6.99%-0.075
1Y0.562025-11-18-34.41%0.312
2Y0.672024-11-18-44.43%—
5Y0.042021-11-18+860.13%0.212
ELTP Stock Summary

ELITE PHARMS INC (OTC:ELTP) stock price today is $0.37, and today's volume is 1,080,937. ELTP is up 0.997% today. The 30 day average volume is 752,987. ELTP market cap is $394.89M with 1.07B shares outstanding.